The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

H5N1 vaccines have been previously licensed, and millions are in the national stockpile. But even with the news of the ...

A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S.

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...